|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rogers JE, Sewastjanow-Silva M, Waters RE
and Ajani JA: Esophageal cancer: Emerging therapeutics. Expert Opin
Ther Targets. 26:107–117. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan J, Liu Z, Mao X, Tong X, Zhang T, Suo
C and Chen X: Global trends in the incidence and mortality of
esophageal cancer from 1990 to 2017. Cancer Med. 9:6875–6887. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Uhlenhopp DJ, Then EO, Sunkara T and
Gaduputi V: Epidemiology of esophageal cancer: Update in global
trends, etiology and risk factors. Clin J Gastroenterol.
13:1010–1021. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang K, Zhang P, Zhang Z, Youn JY, Wang
C, Zhang H and Cai H: Traditional Chinese Medicine (TCM) in the
treatment of COVID-19 and other viral infections: Efficacies and
mechanisms. Pharmacol Ther. 225:1078432021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang S, Zhang Z, Li W, Kong F, Yi P,
Huang J, Mao D, Peng W and Zhang S: Network Pharmacology-Based
prediction and verification of the active ingredients and potential
targets of Zuojinwan for treating colorectal cancer. Drug Des Devel
Ther. 14:2725–2740. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang Z, Zhang Q, Yu L, Zhu J, Cao Y and
Gao X: The signaling pathways and targets of traditional Chinese
medicine and natural medicine in triple-negative breast cancer. J
Ethnopharmacol. 264:1132492021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jingjing H, Hongna H, Xiaojiao W, Yan G,
Yuexue Z and Yueqiang H: Bie Jia Jian pill enhances the
amelioration of bone mesenchymal stem cells on hepatocellular
carcinoma progression. J Nat Med. 76:49–58. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kan Y, Song M, Cui X, Yang Q, Zang Y, Li
Q, Li Y, Cai W, Chen Y, Weng X, et al: Muyin extract inhibits
non-small-cell lung cancer growth by inducing autophagy and
apoptosis in vitro and in vivo. Phytomedicine. 96:1538342022.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kong L, Lu X, Chen X, Wu Y, Zhang Y, Shi H
and Li J: Qigesan inhibits esophageal cancer cell invasion and
migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal
transition. Aging (Albany NY). 12:9714–9725. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu Z, Zhao Y, Yu F, Shi H and Li J:
Qigefang inhibits migration, invasion, and metastasis of ESCC by
Inhibiting Gas6/Axl signaling pathway. Recent Pat Anticancer Drug
Discov. 16:285–294. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li H, Ma C, Chang S, Xi X, Shao S, Chen M,
Ren J, Sun M and Dong L: Traditional Chinese Medicine decoctions
improve longevity following diagnosis with stage IV esophageal
squamous cell carcinoma: A retrospective analysis. Int J Gen Med.
15:1665–1675. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Funakoshi-Tago M, Okamoto K, Izumi R, Tago
K, Yanagisawa K, Narukawa Y, Kiuchi F, Kasahara T and Tamura H:
Anti-inflammatory activity of flavonoids in Nepalese propolis is
attributed to inhibition of the IL-33 signaling pathway. Int
Immunopharmacol. 25:189–198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hirano T, Abe K, Gotoh M and Oka K: Citrus
flavone tangeretin inhibits leukaemic HL-60 cell growth partially
through induction of apoptosis with less cytotoxicity on normal
lymphocytes. Br J Cancer. 72:1380–1388. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park KR, Yun HM, Quang TH, Oh H, Lee DS,
Auh QS and Kim EC: 4-Methoxydalbergione suppresses growth and
induces apoptosis in human osteosarcoma cells in vitro and in vivo
xenograft model through down-regulation of the JAK2/STAT3 pathway.
Oncotarget. 7:6960–6971. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li R, Xu CQ, Shen JX, Ren QY, Chen DL, Lin
MJ, Huang RN, Li CH, Zhong RT, Luo ZH, et al: 4-Methoxydalbergione
is a potent inhibitor of human astroglioma U87 cells in vitro and
in vivo. Acta Pharmacol Sin. 42:1507–1515. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Du H, Tao T, Xu S, Xu C, Li S, Su Q, Yan
J, Liu B and Li R: 4-Methoxydalbergione inhibits bladder cancer
cell growth via inducing autophagy and inhibiting Akt/ERK signaling
pathway. Front Mol Biosci. 8:7896582022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yao J, Cui Q, Fan W, Ma Y, Chen Y, Liu T,
Zhang X, Xi Y, Wang C, Peng L, et al: Single-cell transcriptomic
analysis in a mouse model deciphers cell transition states in the
multistep development of esophageal cancer. Nat Commun.
11:37152020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ekheden I, Ludvigsson JF, Yin L, Elbe P
and Ye W: Esophageal abnormalities and the risk for
gastroesophageal cancers-a histopathology-register-based study in
Sweden. Eur J Epidemiol. 37:401–411. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Keeley BR, Islami F, Pourshams A, Poustchi
H, Pak JS, Brennan P, Khademi H, Genden EM, Abnet CC, Dawsey SM, et
al: Prediagnostic serum levels of inflammatory biomarkers are
correlated with future development of lung and esophageal cancer.
Cancer Sci. 105:1205–1211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu C, Wang M, Zhou Q and Shi H:
Associations of changes in intestinal flora and inflammatory
factors with prognosis of patients with esophageal cancer. J
Healthc Eng. 2022:24263012022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sugawara K, Yagi K, Okumura Y, Aikou S,
Yamashita H and Seto Y: Survival prediction capabilities of
preoperative inflammatory and nutritional status in esophageal
squamous cell carcinoma patients. World J Surg. 46:639–647. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Y, Wang D, Peng H, Chen X, Han X, Yu
J, Wang W, Liang L, Liu Z, Zheng Y, et al: Epigenetically
upregulated oncoprotein PLCE1 drives esophageal carcinoma
angiogenesis and proliferation via activating the PI-PLCℇ-NF-κB
signaling pathway and VEGF-C/Bcl-2 expression. Mol Cancer.
18:12019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sojoodi M, Erstad DJ, Barrett SC, Salloum
S, Zhu S, Qian T, Colon S, Gale EM, Jordan VC, Wang Y, et al:
Peroxidasin deficiency re-programs macrophages toward
pro-fibrolysis function and promotes collagen resolution in liver.
Cell Mol Gastroenterol Hepatol. 13:1483–1509. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Balzano T, Arenas YM, Dadsetan S, Forteza
J, Gil-Perotin S, Cubas-Nuñez L, Casanova B, Gracià F,
Varela-Andrés N, Montoliu C, et al: Sustained hyperammonemia
induces TNF-a IN Purkinje neurons by activating the TNFR1-NF-κB
pathway. J Neuroinflammation. 17:702020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamada T, Osawa S, Ikuma M, Kajimura M,
Sugimoto M, Furuta T, Iwaizumi M and Sugimoto K: Guggulsterone, a
plant-derived inhibitor of NF-TB, suppresses CDX2 and COX-2
expression and reduces the viability of esophageal adenocarcinoma
cells. Digestion. 90:208–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao J, Bi W, Xiao S, Lan X, Cheng X,
Zhang J, Lu D, Wei W, Wang Y, Li H, et al: Neuroinflammation
induced by lipopolysaccharide causes cognitive impairment in mice.
Sci Rep. 9:57902019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sousa FBM, Pacheco G, Oliveira AP, Nicolau
LAD, Lopes ALF, Ferreira-Fernandes H, Pinto GR and Medeiros JVR:
Mechanism of preservation of the intestinal mucosa architecture and
NF-κB/PGE2 reduction by hydrogen sulfide on cholera toxin-induced
diarrhea in mice. Life Sci. 284:1198692021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Voce DJ, Bernal GM, Cahill KE, Wu L,
Mansour N, Crawley CD, Campbell PS, Arina A, Weichselbaum RR and
Yamini B: CDK1 is up-regulated by temozolomide in an NF-κB
dependent manner in glioblastoma. Sci Rep. 11:56652021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han D, Zhu S, Li X, Li Z, Huang H, Gao W,
Liu Y, Zhu H and Yu X: The NF-κB/miR-488/ERBB2 axis modulates
pancreatic cancer cell malignancy and tumor growth through cell
cycle signaling. Cancer Biol Ther. 23:294–309. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gu P, Zhang M, Zhu J, He X and Yang D:
Suppression of CDCA3 inhibits prostate cancer progression via
NF-κB/cyclin D1 signaling inactivation and p21 accumulation. Oncol
Rep. 47:422022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Liu X, Yang Y and Yang D: Cyclin
D1 mediated by the nuclear translocation of nuclear factor kappa B
exerts an oncogenic role in lung cancer. Bioengineered.
13:6866–6879. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao Y, Liu C, Gao Z, Shao D, Zhao X, Wei
Q and Ma B: G protein-coupled estrogen receptor 1 mediates
proliferation and adipogenic differentiation of goat
adipose-derived stem cells through ERK1/2-NF-κB signaling pathway.
Acta Biochim Biophys Sin (Shanghai). 54:494–503. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang W and Wang Y: Activation of
RIPK2-mediated NOD1 signaling promotes proliferation and invasion
of ovarian cancer cells via NF-κB pathway. Histochem Cell Biol.
157:173–182. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zu Y, Ping W, Deng T, Zhang N, Fu X and
Sun W: Lipopolysaccharide-induced toll-like receptor 4 signaling in
esophageal squamous cell carcinoma promotes tumor proliferation and
regulates inflammatory cytokines expression. Dis Esophagus. 30:1–8.
2017.PubMed/NCBI
|
|
36
|
Kawanishi S, Ohnishi S, Ma N, Hiraku Y and
Murata M: Crosstalk between DNA Damage and inflammation in the
multiple steps of carcinogenesis. Int J Sci. 18:18082017.
|
|
37
|
Holleczek B, Schottker B and Brenner H:
Helicobacter pylori infection, chronic atrophic gastritis and risk
of stomach and esophagus cancer: Results from the prospective
population-based ESTHER cohort study. Int J Cancer. 146:2773–2783.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou Q, Wei Y, Zhai H, Li S, Xu R and Li
P: Comorbid early esophageal cancer and Gongylonema pulchrum
infection: A case report. BMC Gastroenterol. 21:3052021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kawasaki M, Ikeda Y, Ikeda E, Takahashi M,
Tanaka D, Nakajima Y, Arakawa S, Izumi Y and Miyake S: Oral
infectious bacteria in dental plaque and saliva as risk factors in
patients with esophageal cancer. Cancer. 127:512–519. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fujiwara N, Kitamura N, Yoshida K,
Yamamoto T, Ozaki K and Kudo Y: Involvement of fusobacterium
species in oral cancer progression: A literature review including
other types of cancer. Int J Mol Sci. 21:62072020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tian C, Chen K, Gong W, Yoshimura T, Huang
J and Wang JM: The G-Protein coupled formyl peptide receptors and
their role in the progression of digestive tract cancer. Technol
Cancer Res Treat. 19:15330338209732802020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu CH, Chen Z, Chen K, Liao FT, Chung CE,
Liu X, Lin YC, Keohavong P, Leikauf GD and Di YP:
Lipopolysaccharide-Mediated chronic inflammation promotes tobacco
carcinogen-induced lung cancer and determines the efficacy of
immunotherapy. Cancer Res. 81:144–157. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li M, Liu H, Shao H, Zhang P, Gao M, Huang
L, Shang P, Zhang Q, Wang W and Feng F: Glyburide attenuates B(a)p
and LPS-induced inflammation-related lung tumorigenesis in mice.
Environ Toxicol. 36:1713–1722. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Watanabe M, Otake R, Kozuki R, Toihata T,
Takahashi K, Okamura A and Mamura Y: Recent progress in
multidisciplinary treatment for patients with esophageal cancer.
Surg Today. 50:12–20. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zheng L, Jiang J, Liu Y, Zheng X and Wu C:
Correlations of recurrence after radical surgery for esophageal
cancer with glucose-lipid metabolism, insulin resistance,
inflammation, stress and serum p53 expression. J BUON.
24:1666–1672. 2019.PubMed/NCBI
|
|
46
|
Zhang M, Zhang L, Cui M, Ye W, Zhang P,
Zhou S and Wang J: miR-302b inhibits cancer-related inflammation by
targeting ERBB4, IRF2 and CXCR4 in esophageal cancer. Oncotarget.
8:49053–49063. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Abdel-Latif MMM, Babar M, Kelleher D and
Reynolds JV: A pilot study of the impact of Vitamin C
supplementation with neoadjuvant chemoradiation on regulators of
inflammation and carcinogenesis in esophageal cancer patients. J
Cancer Res Ther. 15:185–191. 2019.PubMed/NCBI
|
|
48
|
Komal K, Chaudhary S, Yadav P, Parmanik R
and Singh M: The therapeutic and preventive efficacy of curcumin
and its derivatives in esophageal cancer. Asian Pac J Cancer Prev.
20:1329–1337. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cui L, Xu F, Wang M, Li L, Qiao T, Cui H,
Li Z and Sun C: Dietary natural astaxanthin at an early stage
inhibits N-nitrosomethylbenzylamine-induced esophageal cancer
oxidative stress and inflammation via downregulation of NFκB and
COX2 in F344 rats. Onco Targets Ther. 12:5087–5096. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cui L, Xu F, Wu K, Li L, Qiao T, Li Z,
Chen T and Sun C: Anticancer effects and possible mechanisms of
lycopene intervention on N-methylbenzylnitrosamine induced
esophageal cancer in F344 rats based on PPARү1. Eur J
Pharmacol. 881:1732302020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Han S, Wang Y, Ma J, Wang Z, Wang HD and
Yuan Q: Sulforaphene inhibits esophageal cancer progression via
suppressing SCD and CDH3 expression, and activating the
GADD45B-MAP2K3-p38-p53 feedback loop. Cell Death Dis. 11:7132020.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hong P, Liu QW, Xie Y, Zhang QH, Liao L,
He QY, Li B and Xu WW: Echinatin suppresses esophageal cancer tumor
growth and invasion through inducing AKT/mTOR-dependent autophagy
and apoptosis. Cell Death Dis. 11:5242020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kim DC, Lee DS, Ko W, Kim KW, Kim HJ, Yoon
CS, Oh H and Kim YC: Heme Oxygenase-1-Inducing Activity of
4-Methoxydalbergione and 4′-Hydroxy-4-methoxydalbergione from
Dalbergia odorifera and their anti-inflammatory and cytoprotective
effects in murine hippocampal and BV2 microglial cell line and
primary rat microglial cells. Neurotox Res. 33:337–352. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sun K, Su C, Li W, Gong Z, Sha C and Liu
R: Quality markers based on phytochemical analysis and
anti-inflammatory screening: An integrated strategy for the quality
control of Dalbergia odorifera by UHPLC-Q-Orbitrap HRMS.
Phytomedicine. 84:1535112021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Funakoshi-Tago M, Ohsawa K, Ishikawa T,
Nakamura F, Ueda F, Narukawa Y, Kiuchi F, Tamura H, Tago K and
Kasahara T: Inhibitory effects of flavonoids extracted from
Nepalese propolis on the LPS signaling pathway. Int
Immunopharmacol. 40:550–560. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gergen AK, Kohtz PD, Halpern AL, White AM,
Meng X, Fullerton DA and Weyant MJ: Statins Inhibit Toll-Like
Receptor 4-Mediated growth of human esophageal adenocarcinoma
cells. J Surg Res. 260:436–447. 2021. View Article : Google Scholar : PubMed/NCBI
|
